The Trojan Investment Funds all have an absolute return objective and any comparisons against indices are for illustrative purposes only. The Trojan Capital Fund is an equity fund that aims to provide substantial capital growth over the longer term.
Name | % Net Assets |
---|---|
Royal Dutch Shell B | 5.7% |
BP | 5.4% |
Lyxor Gold Bullion | 4.8% |
BIC (France) | 4.1% |
GlaxoSmithKline | 4.0% |
Johnson & Johnson | 3.7% |
Tesco | 3.7% |
BG Group | 3.6% |
Imperial Tobacco | 3.4% |
British American Tobacco | 3.3% |
Key | % Net Assets |
---|---|
Royal Dutch Shell B | 5.7% |
BP | 5.4% |
Lyxor Gold Bullion | 4.8% |
BIC (France) | 4.1% |
Other | 80% |
Date | 21-Nov-2024 |
---|---|
NAV | 520.40p |
Currency | GBP |
Change | -0.15p |
% | -0.03% |
YTD change | 64.91p |
YTD % | 14.25% |
Fund Inception | 06/03/2006 |
---|---|
Fund Manager | Ruth Keattch |
TER | 1.12 (31-Jan-2014) |
Minimum Investment | |
---|---|
Initial | £10000 |
Additional | £100,000 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.25 |
You are here: research